Hemoccult II Screening for Bowel Cancer: Will Family Practice Patients Accept It?

Area of Science:

• Gastroenterology
• Public Health
• Preventive Medicine

Background:

• Colorectal cancer screening is vital for early detection and improved patient outcomes.
• The Hemoccult II® fecal occult blood test is a common screening tool.
• Patient acceptability significantly impacts the success of screening programs.

Purpose of the Study:

• To assess patient acceptability and compliance rates for Hemoccult II® screening.
• To identify factors influencing patient non-compliance with the screening test.
• To provide insights for improving physician strategies to enhance patient acceptance.

Main Methods:

• A compliance study was conducted across 17 family practices in London, Ontario.
• Patient reactions were evaluated using both retrospective and prospective questionnaires.
• Factors affecting compliance, such as test experience and medication use, were analyzed.

Main Results:

• Patient non-compliance was primarily linked to the test's unpleasantness and required dietary preparation.
• Forgetfulness and the concurrent use of other medications were also identified as significant barriers.
• Understanding these factors is key to addressing patient concerns.

Conclusions:

• Patient acceptability is a critical factor for the successful implementation of bowel cancer screening programs.
• Addressing patient-reported issues like unpleasantness, dietary restrictions, and medication interactions can improve compliance.
• Physicians can leverage this knowledge to enhance patient education and support, thereby increasing screening test acceptance.